England's chief pharmaceutical officer Keith Ridge to retire

NHS England and NHS Improvement (NHSE&I) has confirmed it is seeking a new chief pharmaceutical officer to replace Keith Ridge, who will retire from the role in February.

keith_ridge_620x413px_1.jpg
Keith Ridge was appointed England's chief pharmaceutical officer in 2006

NHSE&I confirmed to C+D today (July 30) that Dr Ridge will retire in February 2022, at which point he would have held the position of NHSE&I's and the government's “most senior advisor on pharmacy and medicines use” for 16 years.

Prior to that, he was director of pharmacy at the University Hospital Birmingham NHS Foundation Trust.

Announcing his departure, Professor Steve Powis, national medical director, thanked Dr Ridge “for his outstanding contribution to the NHS, particularly in transforming pharmacy’s clinical input to NHS services, for his energy and dedication to patients, and the integrity with which he has fulfilled his leadership role”.

“I am personally grateful for his advice on key issues such as antimicrobial resistance, medicines safety and supply, controlled drugs, and medicines regulation; and his contribution to key national clinical programmes and, crucially, the COVID-19 vaccination programme which have brought lasting improvements to patient care,” he added.

Key moments in post

Community pharmacy has undergone some significant changes during Dr Ridge’s tenure, including weathering the 12% cut to funding in 2016. In 2013, he told a launch event for the Royal Pharmaceutical Society's (RPS) future of pharmacy report that there were "too many pharmacies" in England.

Early on in the role, he helped deliver a new system for the governance of controlled drugs following the Shipman inquiry, and led the establishment of the first independent professional regulator for pharmacy professionals in the form of the General Pharmaceutical Council.

According to NHSE&I, Dr Ridge's stewardship saw the introduction of medicines optimisation in pharmacies in England, as well as new standards for the initial education and training of pharmacists that were published in January 2021.

He has been a keen advocate of the upskilling of pharmacy technicians and encouraging more “clinical” pharmacists to join GP surgeries and primary care networks. He has also been a keen proponent of the hub-and-spoke dispensing model for pharmacy as a method of freeing up "highly trained staff" to work more closely with patients.

Dr Ridge was also involved in securing the continued supply of medicines as the UK left the EU and throughout the COVID-19 pandemic, NHSE&I added.

In March this year, he launched the Joint National Plan for Inclusive Pharmacy Practice in England, an initiative with NHSE&I the RPS and the Association of Pharmacy Technicians UK (APTUK) “to develop and embed inclusive pharmacy professional practice into everyday care for patients”.

Requirements for the new candidates

job advert posted on the NHSE&I website yesterday (July 29) invites candidates to apply to become the NHS's and government's “principal advisor on medicines and pharmacy policy development and delivery”, providing professional leadership to pharmacists and pharmacy technicians across the country.

According to the job description and person specification for the role, “particular challenges are to stimulate developments in, and modernisation of, the practice of pharmacy, and the safe, clinical, cost effective optimal use of medicines so as the fulfil the intentions set out in the NHS long-term plan, taking into account the forthcoming Health Bill and the consequences and lessons of the COVID-19 pandemic”.

Applicants must be “senior pharmacy leaders” registered with the General Pharmaceutical Council, with a master's degree in pharmacy (or equivalent) and a postgraduate or management qualification, or equivalent experience, NHSE&I specified.

Applications are open until August 19. 

The news comes after NHSE&I announced Amanda Pritchard will become chief executive officer of NHS England from August 1, the first woman in the health service’s history to hold the post.

Twitter reaction

Sign in or register for free

Latest from News

All the headlines: Community pharmacy funding deal

 
• By 
 • comment0

Find out everything you need to know about the government’s plans for community pharmacy – as outlined in this week’s long-awaited pharmacy funding deal.

Pharmacy stop-smoking service expands to ‘non-registered’ staff

 
• By 
 • comment0

The new pharmacy contract has expanded who can deliver the smoking cessation service, as well as adding the provision of two drugs via PGDs.

Revealed: 2024/25 contract cash uplift already paid

 
• By 
 • comment5

Following this week’s announcement of the long-awaited pharmacy funding deal, C+D has learned that contractors have already received the additional £106 million in retrospective funding for 2024/25.

More from Politics

New evidence Brexit caused UK medicines shortages

 
• By 
 • comment

A health and social care think tank has revealed that the “elevated and troubling level” of medicine shortages in the UK can be blamed on Brexit.

Risk pharmacies ‘deprioritised’ if GP role grows, report warns

 
• By 
 • comment

A Westminster think tank has said that the government’s proposed Neighbourhood Health Service, which plans to scale up general practice, could put community pharmacies at risk of being “deprioritised”.